Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Infographic: GiACTA - Trial of Tocilizumab in Giant-Cell Arteritis | Eye
(a) Final prednisone wallets developed and approved for the GiACTA ...
GiACTA Trial – 膠原病の歩き方
GiACTA Trial Results: Sustained Remission Rates and Flares | Download ...
GiACTA Study Shows Benefit of Adding Tocilizumab to Steroid Taper in ...
GiACTA Trial | 膠原病の歩き方
Baseline characteristics of GiACTA patients, stratified by disease ...
Baseline features of the GIACTA cohort | Download Scientific Diagram
How would you taper tocilizumab in a patient treated with the GIACTA 26 ...
Three-year GiACTA trial results revealed - Medical Republic
Lead Investigator Discusses Implications of the GiACTA Trial for GCA ...
GiACTA trial | Videos & Movies on Vimeo
The GiACTA Trial | New England Journal of Medicine
What part 2 of the GiACTA trial means for Australia - Rheumatology Republic
RT @drdavidliew: Tocilizumab in GCA - three year data from GiACTA on ...
RT @RichardPAConway: Patel @NaomiRheumMD et al. HbA1c in GiACTA ...
(PDF) FRI0248 Baseline Data on Patients in Giacta (Tocilizumab in Giant ...
Étude GIACTA sur le tocilizumab en artérite | PDF | Essai clinique ...
Phase 3 GiACTA Trial Results for TCZ in Giant Cell Arteritis ...
Giant Cell Arteritis: Timely Diagnosis and Emerging Treatment ...
Giant Cell Arteritis And The Rapid Rise Of Tocilizumab: Are Steroids ...
巨細胞性動脈炎の80歳以上の患者へのTocilizumabの有効性・安全性 - 膠原病・リウマチ一人抄読会
Léčba obrovskobuněčné arteriitidy – současnost a o... | proLékaře.cz
Profile of tocilizumab and its potential in the treatment of giant cel | EB
HERA SYMPOSIUM(Healing the Erosion of Rheumatoid Arthiritis) ②:후생신보
Metabolic bone health considerations in giant cell arteritis and ...
Long-term effect of tocilizumab in patients with giant cell arteritis ...
GCA joint symposium ②:후생신보
Full article: Safety and Efficacy of Long-Term Tocilizumab in a Cohort ...
GiACTA: Giant cell arteritis remission maintained in 42% of patients ...
Trial of Tocilizumab in Giant-Cell Arteritis | New England Journal of ...
Giant Cell Arteritis Actemra Trial – YAXN
(PDF) Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell ...
The Efficacy and Safety of Tocilizumab in Patients with Giant Cell ...
Effects of Baseline Prednisone Dose on Remission and Disease Flare in ...
Design of the Tocilizumab in Giant Cell Arteritis Trial - Unizony ...
OP0140 LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ...
Characteristics of patients with major relapse in giant cell arteritis ...
Measuring treatment outcomes and change in disease activity in giant ...
(PDF) Tocilizumab in giant cell arteritis: differences between the ...
Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination ...
GCA and PMR New Drugs | RheumNow
(PDF) A Multicenter Series of Giant Cell Arteritis Patients from ...
(PDF) The Effects of Treatment on Body Mass Index in Giant Cell ...
Trial of Tocilizumab in Giant-Cell Arteritis | NEJM
The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c ...
Time to Flare in Patients with New-Onset versus Relapsing Giant Cell ...
Table 3 from Design of the Tocilizumab in Giant Cell Arteritis Trial ...
Efficacy and Safety of Tocilizumab in Patients with Giant Cell ...
RT @ericdeinmd: #RNL2023 Year in Review New Drugs in Old Disease? GCA ...
FRI0220 EFFICACY OF ADJUNCTIVE METHOTREXATE IN PATIENTS WITH GIANT CELL ...
Histogram of glucocorticoid‐related toxicity scores in all patients and ...
Patients’ Baseline Characteristics, but Not Tocilizumab Exposure ...
Фармакоэкономика. Центр фармакоэкономических исследований ...
Unveiling New Avenues in Giant-Cell Arteritis Treatment
Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis ...
FRI0262 CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS WITH ...
Giant Cell Arteritis | The Effects of Treatment on Body Mass Index in ...
Biologic Therapies for Giant Cell Arteritis | BTT | Dove Medical Press
Riktlinjer för utredning, behandling och uppföljning av ...
Baseline Glucocorticoid Toxicity in the Treatment of Giant Cell ...
Biological treatments in giant cell arteritis & Takayasu arteritis ...
Giant Cell Arteritis 2023 _ Giant Cell Arteritis (Temporal Arteritis ...
Anterior ischemic optic neuropathy.pptx
Subcutaneous Injections for GCA | ACTEMRA® (tocilizumab)
A JAKi in Giant Cell Arteritis: The Impact of Glucocorticoid Tapering ...
In Newly Diagnosed Giant Cell Arteritis in a Real Life Setting Relapses ...
PPT - GCA, Jättecellsarterit diagnos & behandling PowerPoint ...
SAT0275 MAINTAINED BENEFIT IN HEALTH-RELATED QUALITY OF LIFE OF ...
What are the major randomized clinical trials evaluating glucocorticoid ...
Advances in the Treatment of Giant Cell Arteritis
Selected Vasculitides | AMBOSS Rotation Prep
Treatment of Giant Cell Arteritis (GCA)
RT @RichardPAConway: Patel @NaomiRheumMD et al. Baseline GTI in GCA in ...
OP0131 Optimal dose of tocilizumab for the treatment of giant cell ...
Tocilizumab in Monotherapy vs. Combined in Aortitis Associated with ...
Giant Cell Arteritis Management | Evidence Evolution | AttendMe
Weekly tocilizumab provides durable benefits for giant cell arteritis ...
IL-6: To immunity and beyond | Considerations in Medicine
What is the recommended duration of Actemra (Tocilizumab) use in Giant ...
Hospitalist ~なんでも無い科医の勉強ノート~: 巨細胞性動脈炎(GCA)に対するトリシズマブ(アクテムラ®)
Bar chart displaying final GCA diagnosis by GCAPS risk group. 224x131mm ...
